Mineralys Therapeutics, Inc. MLYS Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s other income (expense)?
- Mineralys Therapeutics, Inc. (MLYS) reported other income (expense) of $6M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Mineralys Therapeutics, Inc.'s other income (expense) increased by 168.4% year-over-year, from $2.24M to $6M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s other income (expense)?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s other income (expense) has grown at a 111.8% compound annual growth rate (CAGR), from $1.68M to $15.95M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.